Cutaneous Lymphoma — Trials

Cutaneous Lymphoma — Trials · CancerIndex

Clinical trials

Registered studies

360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 69
Recruiting: 32
Ph III recruiting: 0
Growth YoY: —
Industry share: 19%
Top sponsor: Mayo Clinic
Termination share: 37.6%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (77)

clinicaltrialsPublishedShowing 1–18 of 18 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06854653	A Phase 2 Study of PTX 100 in Patients With Relapsed/Refractory CTCL	recruiting	Phase 2	115	Prescient Therapeutics, Ltd.INDUSTRY	4	Sep 9, 2026	clinicaltrials
NCT04930653	Extracorporeal Photopheresis and Mogamulizumab for the Treatment of Erythrodermic Cutaneous T Cell Lymphoma	recruiting	Phase 2	34	City of Hope Medical CenterOTHER	1	Sep 2, 2026	clinicaltrials